A Study of Acequias Contamination & Association of Infectious Diseases in Peru
NCT ID: NCT03074760
Last Updated: 2017-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
450 participants
OBSERVATIONAL
2017-03-16
2017-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pilot Study Examining for the Presence of Fecal Coliforms and Tropical Diseases in Peru
NCT03078894
Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
NCT03676140
PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )
NCT03664063
Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin
NCT03570814
Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults
NCT03435718
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Contaminated acequias
Adenovirus
Diagnostic test for the presence of the adenovirus in the population groups
Rotavirus
Diagnostic test for the presence of the Rotavirus in the population groups
H. pylori
Diagnostic test for the presence of H. pylori infection in the population groups
Non-contaminated acequias
Adenovirus
Diagnostic test for the presence of the adenovirus in the population groups
Rotavirus
Diagnostic test for the presence of the Rotavirus in the population groups
H. pylori
Diagnostic test for the presence of H. pylori infection in the population groups
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adenovirus
Diagnostic test for the presence of the adenovirus in the population groups
Rotavirus
Diagnostic test for the presence of the Rotavirus in the population groups
H. pylori
Diagnostic test for the presence of H. pylori infection in the population groups
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older
* Consent to participate
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BioRed LLC
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert E Goode
Role: PRINCIPAL_INVESTIGATOR
Campbell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BioRed
Hacienda Pucala, Lambayeque, Peru
BioRed
Pátapo, Lambayeque, Peru
BioRed
Pimentel, Lambayeque, Peru
BioRed
Pomalca, Lambayeque, Peru
BioRed
Tumán, Lambayeque, Peru
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Lozado Dominguez
Role: primary
Lozado Dominguez
Role: primary
Lozado Dominguez
Role: primary
Lozado Dominguez
Role: primary
Lozado Dominguez
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CUIRBRG273
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.